Results 21 to 30 of about 232,754 (343)

Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment

Critical Care, 2017
Methicillin-resistant Staphylococcus aureus (MRSA) infection is still a major global healthcare problem. Of concern is S. aureus bacteremia, which exhibits high rates of morbidity and mortality and can cause metastatic or complicated infections such as ...
A. Hassoun, P. Linden, B. Friedman
semanticscholar   +1 more source

Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series

Open Forum Infectious Diseases, 2020
Background Previous viral pandemics have shown that secondary bacterial infections result in higher morbidity and mortality, with Staphylococcus aureus being the primary causative pathogen. The impact of secondary S.
Jaclyn A. Cusumano, A. Dupper, Yesha Malik, E. Gavioli, Jaspreet Banga, Ana Berbel Caban, D. Nadkarni, Ajay Obla, Chirag V. Vasa, D. Mazo, D. Altman   +10 more
semanticscholar   +1 more source

Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia

BMC Infectious Diseases, 2022
Background Prior studies have identified that vancomycin resistant enterococcus (VRE) bacteremia that persists for four days or more is an independent predictor of mortality.
Emily Fox, David Ha, Mark Bounthavong, Lina Meng, Emily Mui, Marisa Holubar, Stanley Deresinski, William Alegria   +7 more
doaj   +1 more source

Risk of community- and hospital-acquired bacteremia and profile of antibiotic resistance in children hospitalized with severe acute malnutrition in Niger

International Journal of Infectious Diseases, 2022
Objective: To estimate the prevalence and antibiotic resistance profile of community- and hospital-acquired bacteremia among hospitalized children with severe acute malnutrition in Niger.
Christopher T. Andersen, Céline Langendorf, Souna Garba, Nathan Sayinzonga-Makombe, Christopher Mambula, Isabelle Mouniaman, Kerstin E. Hanson, Rebecca F. Grais, Sheila Isanaka   +8 more
doaj   +1 more source

Prevalence and Predictors of Urinary Tract Infection and Severe Malaria Among Febrile Children Attending Makongoro Health Centre in Mwanza City, North-Western Tanzania. [PDF]

, 2012
In malaria endemic areas, fever has been used as an entry point for presumptive treatment of malaria. At present, the decrease in malaria transmission in Africa implies an increase in febrile illnesses related to other causes among underfives.
A Dzeing-Ella, A Rougemont, B Murray, BHM Wolf, BO Olaleye, CA Guerra, CLSI, D Chandramohan, D De Savigny, E Festo, F Font, FN Okwara, G Raso, GO Akpede, HD Mazigo, J Berkley, J Prada, J Richens, K Kallander, K Panaretto, L Kish, M Gorelick, MF Cotton, N Kayange, P Bahwere, P Bouvier, PW Gething, Q Bassat, RA Hoddon, Roll Back Malaria, S Gove, TJ O'Dempsey, V Batwala, V D'Acremont, World Health Organization, World Health Organization, WP O'Meara, Y Panahi   +37 more
core   +1 more source

Mycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score. [PDF]

PLoS ONE, 2013
When manifested as Mycobacterium tuberculosis (MTB) bacteremia, disseminated MTB infection clinically mimics other serious blood stream infections often hindering early diagnosis and initiation of potentially life-saving anti-tuberculosis therapy.
Shevin T Jacob, Patricia B Pavlinac, Lydia Nakiyingi, Patrick Banura, Jared M Baeten, Karen Morgan, Amalia Magaret, Yuka Manabe, Steven J Reynolds, W Conrad Liles, Anna Wald, Moses L Joloba, Harriet Mayanja-Kizza, W Michael Scheld   +13 more
doaj   +1 more source

Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. [PDF]

, 2017
The practice of phage therapy, which uses bacterial viruses (phages) to treat bacterial infections, has been around for almost a century. The universal decline in the effectiveness of antibiotics has generated renewed interest in revisiting this practice.
Koskella, Britt, Lin, Derek, Lin, Henry
core   +1 more source

Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial.

Clinical Infectious Diseases, 2018
Background Gram-negative bacteremia is a major cause of morbidity and mortality in hospitalized patients. Data to guide the duration of antibiotic therapy are limited. Methods Randomized, multicenter, open-label, non-inferiority trial.
D. Yahav, E. Franceschini, Fidi Koppel, A. Turjeman, T. Babich, R. Bitterman, A. Neuberger, Nesrin Ghanem-Zoubi, A. Santoro, N. Eliakim‐Raz, B. Pertzov, T. Steinmetz, A. Stern, Y. Dickstein, Elias Maroun, H. Zayyad, J. Bishara, D. Alon, Y. Edel, E. Goldberg, C. Venturelli, C. Mussini, L. Leibovici, M. Paul   +23 more
semanticscholar   +1 more source

Relapsing cellulitis associated with Campylobacter coli bacteremia in a Good’s syndrome patient: a case report

BMC Infectious Diseases, 2022
Background Good’s syndrome (GS) is characterized by immunodeficiency, and patients diagnosed with GS are susceptible to infection or even bacteremia, which is the most evident complication. Campylobacter coli (C.
Lei Jiang, Jia Gao, Pu Wang, Yuliang Liu
doaj   +1 more source

Routine Changing of Intravenous Administration Sets Does Not Reduce Colonization or Infection in Central Venous Catheters [PDF]

, 2004
Objective: To determine the effect of routine intravascular administration-set changes on central venous catheter (CVC) colonization and catheter related bacteremia (CRB).
Courtney, Mary, Daley, Peter, Lipman, Jeff, Rickard, Claire, Siversen, Rosemary   +4 more
core   +2 more sources